KR0171190B1 - 신규 아스코르브산 유도체 - Google Patents

신규 아스코르브산 유도체 Download PDF

Info

Publication number
KR0171190B1
KR0171190B1 KR1019910004142A KR910004142A KR0171190B1 KR 0171190 B1 KR0171190 B1 KR 0171190B1 KR 1019910004142 A KR1019910004142 A KR 1019910004142A KR 910004142 A KR910004142 A KR 910004142A KR 0171190 B1 KR0171190 B1 KR 0171190B1
Authority
KR
South Korea
Prior art keywords
compound
formula
alkyl
acid
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019910004142A
Other languages
English (en)
Korean (ko)
Other versions
KR910016732A (ko
Inventor
마르시니아 질베르
마틴 그리사 제이.
Original Assignee
게리 디. 스트리트
메렐 다우 파마슈티칼스 인크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게리 디. 스트리트, 메렐 다우 파마슈티칼스 인크 filed Critical 게리 디. 스트리트
Publication of KR910016732A publication Critical patent/KR910016732A/ko
Application granted granted Critical
Publication of KR0171190B1 publication Critical patent/KR0171190B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
KR1019910004142A 1990-03-16 1991-03-15 신규 아스코르브산 유도체 Expired - Fee Related KR0171190B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90400731.7 1990-03-16
EP90400731A EP0446539A1 (en) 1990-03-16 1990-03-16 Novel ascorbic acid derivatives

Publications (2)

Publication Number Publication Date
KR910016732A KR910016732A (ko) 1991-11-05
KR0171190B1 true KR0171190B1 (ko) 1999-02-01

Family

ID=8205691

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910004142A Expired - Fee Related KR0171190B1 (ko) 1990-03-16 1991-03-15 신규 아스코르브산 유도체

Country Status (21)

Country Link
US (1) US5175188A (enExample)
EP (2) EP0446539A1 (enExample)
JP (1) JP3029055B2 (enExample)
KR (1) KR0171190B1 (enExample)
CN (1) CN1034415C (enExample)
AT (1) ATE137230T1 (enExample)
AU (1) AU632907B2 (enExample)
CA (1) CA2038416C (enExample)
DE (1) DE69118955T2 (enExample)
DK (1) DK0447325T5 (enExample)
ES (1) ES2089159T3 (enExample)
FI (1) FI97884C (enExample)
GR (1) GR3020411T3 (enExample)
HU (1) HU208004B (enExample)
IE (1) IE910879A1 (enExample)
IL (1) IL97574A (enExample)
NO (1) NO177705C (enExample)
NZ (1) NZ237400A (enExample)
PT (1) PT97041B (enExample)
TW (1) TW213455B (enExample)
ZA (1) ZA911994B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5559251A (en) * 1993-02-05 1996-09-24 Pliva, Farmaceutska Derivatives of amino-ascorbic acid, the processes for their preparation and use
RU2126398C1 (ru) * 1993-02-05 1999-02-20 Плива, Фармацеутска, Кемийска, Прехрамбена и Козметичка Индустрия Дионичко Друштво Загреб Производные аминоаскорбиновой кислоты, способы их получения и производные галоидаскорбиновой кислоты
HRP930131A2 (en) * 1993-02-05 1997-02-28 Bozidar Suskovic Amino-ascorbic acid derivatives, process for the preparation and use thereof
FR2946252B1 (fr) * 2009-06-08 2011-07-29 Fabre Pierre Dermo Cosmetique Bis esters d'acide gras insature sur l'acide ascorbique et leurs utilisations cosmetiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4368330A (en) * 1981-04-30 1983-01-11 Pfizer Inc. Derivatives of L-ascorbic acid and D-erythorbic acid
FI830078A7 (fi) * 1982-01-15 1983-07-16 Lilly Co Eli Askorbiinihappoeettereitä ja niitä lähellä olevia yhdisteitä.
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production
JP2515556B2 (ja) * 1986-08-29 1996-07-10 武田薬品工業株式会社 ヒドロキシブテノライド誘導体およびその製造法
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.

Also Published As

Publication number Publication date
DE69118955D1 (de) 1996-05-30
DE69118955T2 (de) 1996-09-19
NZ237400A (en) 1993-05-26
PT97041B (pt) 1998-07-31
NO177705B (no) 1995-07-31
US5175188A (en) 1992-12-29
CA2038416C (en) 2003-03-11
IL97574A (en) 1995-10-31
FI97884C (fi) 1997-03-10
ZA911994B (en) 1991-12-24
EP0447325A1 (en) 1991-09-18
GR3020411T3 (en) 1996-09-30
CA2038416A1 (en) 1991-09-17
FI911282L (fi) 1991-09-17
HU208004B (en) 1993-07-28
JPH04234869A (ja) 1992-08-24
AU7287891A (en) 1991-10-10
AU632907B2 (en) 1993-01-14
EP0447325B1 (en) 1996-04-24
FI97884B (fi) 1996-11-29
IL97574A0 (en) 1992-06-21
EP0446539A1 (en) 1991-09-18
NO911051L (no) 1991-09-17
DK0447325T5 (da) 1996-05-28
ATE137230T1 (de) 1996-05-15
NO177705C (no) 1995-11-08
FI911282A0 (fi) 1991-03-15
JP3029055B2 (ja) 2000-04-04
KR910016732A (ko) 1991-11-05
IE910879A1 (en) 1991-09-25
CN1034415C (zh) 1997-04-02
TW213455B (enExample) 1993-09-21
PT97041A (pt) 1991-10-31
NO911051D0 (no) 1991-03-15
ES2089159T3 (es) 1996-10-01
HUT56559A (en) 1991-09-30
CN1054978A (zh) 1991-10-02

Similar Documents

Publication Publication Date Title
KR100347423B1 (ko) 구아니딘알킬-1,1-비스포스폰산유도체,이의제조방법및이를함유하는약제
KR0160112B1 (ko) 심장보호 작용을 갖는 토코페롤 유사체
JP3230699B2 (ja) 心臓保護トコフェロ−ル類似体
KR0171190B1 (ko) 신규 아스코르브산 유도체
KR100196973B1 (ko) 콜레스테롤 강하용 약제학적 조성물
KR20010021577A (ko) 골다공증 치료를 위한 디포스폰산 염
EP0061380A1 (fr) Dérivés d'imidazo (1,2-a) pyrimidines, leur préparation et leur application en thérapeutique
US5270336A (en) Ascorbic acid derivatives
US5041554A (en) Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
KR900006132B1 (ko) 젬-디할로-1,8-디아미노-4-아자-옥탄 및 이의 제조방법
EP0381141B1 (en) Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
EP0369083A1 (en) Cardioprotective tocopherol analogs
US3766245A (en) 3,5-dialkoxyalkoxy-4-substituted benzoic acid esters
US5039695A (en) Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
KR950013764B1 (ko) 피로글루타미드 유도체, 그 제조방법, 및 그것을 함유하는 치매증 치료제
FR2513247A1 (fr) Nouveaux composes de methylene-4 mercaptoacyl-1 proline et d'acide methylene-4 mercaptoacyl-1 pipecolique utiles comme medicaments hypotenseurs
EP0381142A2 (en) Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
FR2467850A1 (fr) Derives imidazoliques de 1,5,6,11-tetrahydrobenzo-(5,6)cyclohepta(1,2-b) pyrazolo(4,3-e)pyridines, a action antimicrobienne, et leur procede de preparation
JPWO1998052551A1 (ja) ビスアリール化合物およびこれを含む癌治療剤
KR20050024751A (ko) 비타민 ｅ 유도체 및 이의 제조방법
JPH0574588B2 (enExample)

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20021014

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20031020

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20031020